tiprankstipranks
Trending News
More News >
Shanghai Chicmax Cosmetics Co., Ltd. Class H (HK:2145)
:2145
Hong Kong Market

Shanghai Chicmax Cosmetics Co., Ltd. Class H (2145) AI Stock Analysis

Compare
0 Followers

Top Page

HK:2145

Shanghai Chicmax Cosmetics Co., Ltd. Class H

(2145)

Select Model
Select Model
Select Model
Neutral 61 (OpenAI - 5.2)
Rating:61Neutral
Price Target:
HK$81.00
▲(16.71% Upside)
Shanghai Chicmax Cosmetics Co., Ltd. has a strong financial foundation with robust growth and profitability, which is the most significant factor in its overall score. However, the stock is currently facing bearish technical indicators, which weigh down the score. The valuation is moderate, with a high P/E ratio but a decent dividend yield. The absence of earnings call data and corporate events means these factors do not influence the score.
Positive Factors
High Profitability Margins
Sustained high gross and healthy net margins indicate strong product economics and pricing power. Over 2–6 months this supports reinvestment in brand, marketing and R&D, cushions margin pressure from input cost swings, and underpins long‑term profitability stability.
Very Low Leverage and Strong ROE
Extremely low leverage and a high return on equity give the company durable financial flexibility to fund growth, weather downturns, and pursue M&A without stressing the balance sheet. A strong equity base reduces default risk and supports strategic investments.
Improving Free Cash Flow Growth
Material improvement in free cash flow growth signals enhancing cash generation capacity. Durable FCF growth allows sustained reinvestment in channels and brands, incrementally funds dividends or buybacks, and strengthens ability to deleverage or fund expansion over months.
Negative Factors
Weak Operating Cash Conversion
Very low operating cash flow conversion versus reported earnings suggests earnings rely on non‑cash items or face working capital drag. Structurally weak conversion can limit internally funded investments, constrain liquidity buffers, and raise cyclicality risk over the medium term.
Substantial Gap: FCF vs Net Income
Less than half of net income converting to free cash flow implies durable limits on cash available for capex, dividends, or acquisitions despite profitability. Persistent FCF shortfall versus earnings can force external financing or slow strategic initiatives.
Limited Investor Communication / Visibility
Absence of earnings call disclosure and notable corporate event communication reduces transparency into management strategy and outlook. Over months this limits investor ability to assess execution, guidance credibility, and management quality, raising governance and information risk.

Shanghai Chicmax Cosmetics Co., Ltd. Class H (2145) vs. iShares MSCI Hong Kong ETF (EWH)

Shanghai Chicmax Cosmetics Co., Ltd. Class H Business Overview & Revenue Model

Company DescriptionShanghai Chicmax Cosmetic Co., Ltd., a multi-brand cosmetics company, engages in the research, development, manufacture, and sale of skincare, and maternity and childcare products in China. The company offers a range of cosmetics, such as essence creams, lotions, shampoos, facial masks, and other skincare and hair care products under the KANS, One Leaf, Baby Elephant, BIO-G, asnami, KYOCA, newpage, ARMIYO, and TAZU brands. It also engages in supply chain management activities. The company was formerly known as Shanghai Kaka Cosmetic Co., Ltd. and changed its name to Shanghai Chicmax Cosmetic Co., Ltd. in 2020. Shanghai Chicmax Cosmetic Co., Ltd. was founded in 2003 and is based in Shanghai, the People's Republic of China.
How the Company Makes MoneyChicmax generates revenue through multiple key streams including direct sales of its cosmetics and skincare products through retail channels, e-commerce platforms, and partnerships with beauty retailers. The company also benefits from private label services where it manufactures products for other brands, thus diversifying its income sources. Furthermore, strategic collaborations with distributors and influencers in the beauty industry enhance its market reach and brand visibility, driving sales growth. The company's focus on research and development allows for the continuous introduction of new products, keeping its offerings fresh and appealing to a broad consumer base.

Shanghai Chicmax Cosmetics Co., Ltd. Class H Financial Statement Overview

Summary
Shanghai Chicmax Cosmetics Co., Ltd. demonstrates strong financial performance with robust revenue growth, high profitability margins, and low leverage. The company effectively utilizes its equity to generate returns, although there is room to improve cash conversion efficiency. Overall, the financial statements reflect a well-managed company with a positive growth outlook and financial stability.
Income Statement
Shanghai Chicmax Cosmetics Co., Ltd. shows strong revenue growth with a TTM increase of 4.27%. The company maintains high gross and net profit margins at 75.22% and 11.50%, respectively, indicating robust profitability. EBIT and EBITDA margins are also healthy, reflecting efficient operations. Overall, the income statement reflects a positive growth trajectory and strong profitability.
Balance Sheet
The balance sheet is solid with a low debt-to-equity ratio of 0.05, indicating low leverage and financial stability. The return on equity is impressive at 36.37%, showcasing effective use of equity to generate profits. The equity ratio stands at 61.41%, suggesting a strong equity base relative to total assets. Overall, the balance sheet reflects financial stability and efficient equity utilization.
Cash Flow
Cash flow analysis shows a significant improvement in free cash flow growth at 20.27% TTM, indicating enhanced cash generation capabilities. The operating cash flow to net income ratio is moderate at 0.16, while the free cash flow to net income ratio is 0.44, suggesting room for improvement in cash conversion efficiency. Overall, the cash flow statement indicates positive cash flow growth but highlights potential areas for enhancing cash efficiency.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue7.40B6.79B4.19B2.68B3.62B3.38B
Gross Profit5.53B5.11B2.99B1.70B2.36B2.19B
EBITDA808.01M752.09M676.04M268.88M404.70M403.95M
Net Income904.16M781.21M461.10M147.10M338.89M203.46M
Balance Sheet
Total Assets3.95B3.60B3.13B3.15B2.27B2.22B
Cash, Cash Equivalents and Short-Term Investments799.88M732.71M914.50M1.17B157.26M174.24M
Total Debt300.83M111.67M165.57M728.20M285.04M544.10M
Total Liabilities1.45B1.36B1.10B1.44B1.32B1.64B
Stockholders Equity2.43B2.19B2.01B1.71B949.98M578.95M
Cash Flow
Free Cash Flow473.06M304.38M657.69M-23.51M269.46M124.56M
Operating Cash Flow715.30M546.95M746.16M36.56M335.19M265.97M
Investing Cash Flow-74.30M-187.03M-457.49M-66.78M-55.29M-6.95M
Financing Cash Flow-556.10M-595.67M-737.21M1.03B-289.56M-239.93M

Shanghai Chicmax Cosmetics Co., Ltd. Class H Technical Analysis

Technical Analysis Sentiment
Negative
Last Price69.40
Price Trends
50DMA
81.60
Negative
100DMA
88.14
Negative
200DMA
78.65
Negative
Market Momentum
MACD
-3.00
Negative
RSI
44.71
Neutral
STOCH
70.29
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2145, the sentiment is Negative. The current price of 69.4 is below the 20-day moving average (MA) of 77.66, below the 50-day MA of 81.60, and below the 200-day MA of 78.65, indicating a bearish trend. The MACD of -3.00 indicates Negative momentum. The RSI at 44.71 is Neutral, neither overbought nor oversold. The STOCH value of 70.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2145.

Shanghai Chicmax Cosmetics Co., Ltd. Class H Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
HK$3.24B15.256.65%5.90%9.72%-10.15%
73
Outperform
HK$31.41B12.7710.69%5.36%-3.48%-24.11%
66
Neutral
HK$37.52B15.0229.64%1.84%36.70%22.26%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
61
Neutral
HK$31.55B30.4539.62%2.53%20.78%18.37%
43
Neutral
HK$15.83B-28.59-6.08%5.00%2.79%-170.67%
41
Neutral
HK$981.03M-15.76-12.38%39.29%-71.82%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:2145
Shanghai Chicmax Cosmetics Co., Ltd. Class H
74.60
38.56
106.99%
HK:1044
Hengan International Group Co
27.14
7.90
41.03%
HK:0157
Natural Beauty Bio-Technology
0.49
0.01
2.08%
HK:6601
Cheerwin Group Limited
2.43
0.74
43.79%
HK:2367
Giant Biogene Holding Co. Ltd.
35.74
-15.48
-30.22%
HK:6993
Blue Moon Group Holdings Ltd.
2.77
-0.38
-12.06%

Shanghai Chicmax Cosmetics Co., Ltd. Class H Corporate Events

Shanghai Chicmax Executive Director Boosts Stake with HK$66 Million Share Purchases
Dec 29, 2025

Executive director Luo Yan has significantly increased her stake in Shanghai Chicmax Cosmetic Co., Ltd., purchasing 363,600 H shares on the open market on 29 December 2025 at an average price of about HK$75.46 per share, lifting her total holding to 2,867,200 shares, or 1.39% of the company’s issued share capital. Including earlier purchases made throughout December using her personal funds, Luo’s total share acquisitions for the month reached roughly HK$66.32 million, a move the company highlights as a demonstration of her strong confidence in Shanghai Chicmax’s future development, even as it cautions shareholders and potential investors to exercise care when trading its securities.

The most recent analyst rating on (HK:2145) stock is a Hold with a HK$91.00 price target. To see the full list of analyst forecasts on Shanghai Chicmax Cosmetics Co., Ltd. Class H stock, see the HK:2145 Stock Forecast page.

Shanghai Chicmax Updates Articles of Association Post RSU Issuance
Oct 31, 2025

Shanghai Chicmax Cosmetics Co., Ltd. announced amendments to its Articles of Association following the issuance and allotment of 35,223 H Shares under its RSU Scheme. This adjustment reflects changes in the company’s registered share capital and total number of shares, aligning with resolutions passed at an extraordinary general meeting in December 2023.

The most recent analyst rating on (HK:2145) stock is a Hold with a HK$91.00 price target. To see the full list of analyst forecasts on Shanghai Chicmax Cosmetics Co., Ltd. Class H stock, see the HK:2145 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 31, 2025